A new, biodegradable gel, created by Assistant Professor Quanyin Hu, filled with a cocktail of immune-boosting cytokines and cancer-fighting cells staved off the growth of lingering cancer cells in mice after tumors were surgically removed.
cancer
New Method Targets Disease-Causing Proteins for Destruction
Tang Lab at the School of Pharmacy develops new technique for targeted protein degradation By Eric Hamilton This article originally appeared on UW–Madison’s news page. Scientists at the University of Wisconsin–Madison have developed a way …
A New Way to Target Drug-Resistant Breast Cancer
In collaboration with oncology professor Wei Xu, professors Lingjun Li and Weiping Tang are developing tools to tackle breast cancers that no longer respond to traditional therapies.
School of Pharmacy Welcomes Three Assistant Professors
New faculty members strengthen the School of Pharmacy’s research and education in pediatric pharmacy, drug delivery, and precision medicine.
Degraders: A New Drug Discovery Approach
Professor Weiping Tang harnesses cells’ natural protein disposal system to destroy disease-causing proteins.
PharmD Students Launch Pegasus Health Apps to Improve Cancer Care
After winning the School’s 2019 SHARx Tank competition, PharmD students found Pegasus Health Apps, LLC, to improve the quality of care for cancer patients.
A Carbohydrate-Based Solution to Ovarian Cancer
Through grant from the Carbone Cancer Center, Professor Weiping Tang is starting a collaborative research project to reactivate immune cells against ovarian cancer.
Skin-Deep Search for Answers
Assistant Professor Jun Dai explores the inner workings of skin to find new treatments for inflammation and cancer
Cancer Prevention Through Education
Assistant Professor Olufunmilola Abraham received a grant from American Cancer Society to research Wisconsin teenagers’ knowledge about cancer and caner prevention, which will potentially change their health education.
School Launches New Nanotechnology Center for Drug Delivery
Professors Seungpyo Hong, Sandro Mecozzi, Lingjun Li and Glen Kwon are combining their expertise to create a new research center that will improve the efficacy of new drug leads.